Guangping Lu
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Genomics, phytochemicals, and oxidative stress 3
- Oncology 9
- PARP inhibition in cancer therapy 3
- Lung Cancer Research Studies 2
- Co-authors
- Junlian Gu (15 shared papers)Yufeng Tang (14 shared papers)Yuanfang Guo (13 shared papers)Qingbo Liu (11 shared papers)Mengjie Xiao (10 shared papers)Jiahao Li (9 shared papers)Jingjing Zhang (3 shared papers)Jie Wang (1 shared paper)
- Journals
- Nutrients (3 papers)Acta Pharmaceutica Sinica B (2 papers)Journal of Advanced Research (2 papers)Cellular Physiology and Biochemistry (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Guangping Lu
21 papers receiving 347 citations
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 30
- Cancer Research 92
- Molecular Biology 211
- Cardiology and Cardiovascular Medicine 62
- Oncology 72
Countries citing papers authored by Guangping Lu
This map shows the geographic impact of Guangping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangping Lu more than expected).
Fields of papers citing papers by Guangping Lu
This network shows the impact of papers produced by Guangping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangping Lu. The network helps show where Guangping Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guangping Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 81 | |
| 2 | 2018 | 39 | |
| 3 | 2017 | 30 | |
| 4 | 2022 | 26 | |
| 5 | 2021 | 24 | |
| 6 | 2019 | 22 | |
| 7 | 2020 | 22 | |
| 8 | 2022 | 22 | |
| 9 | 2023 | 21 | |
| 10 | 2022 | 17 | |
| 11 | 2023 | 15 | |
| 12 | 2017 | 9 | |
| 13 | 2021 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 1 | |
| 18 | [Efficacy analysis of sequential surgery after the DCF scheme induction chemotherapy in T2-3 laryngeal carcinoma and hypopharyngeal carcinoma]. | 2015 | 1 |
| 19 | 2020 | 1 | |
| 20 | 2024 | 1 |
About Guangping Lu
Guangping Lu is a scholar working on Molecular Biology, Oncology, Cancer Research, Cardiology and Cardiovascular Medicine and Cell Biology, having authored 22 papers that have together received 350 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), MicroRNA in disease regulation (4 papers), Sirtuins and Resveratrol in Medicine (3 papers), PARP inhibition in cancer therapy (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Pancreatic function and diabetes (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (30 citations), Cancer Research (92 citations), Molecular Biology (211 citations), Cardiology and Cardiovascular Medicine (62 citations) and Oncology (72 citations). Guangping Lu has collaborated with scholars based in China and United States. Frequent co-authors include Junlian Gu, Yufeng Tang, Yuanfang Guo, Qingbo Liu, Mengjie Xiao, Jiahao Li, Jingjing Zhang, Jie Wang, Ting Gao and Xiaohui Zhang. Their work appears in journals such as Nutrients, Acta Pharmaceutica Sinica B, Journal of Advanced Research, Cellular Physiology and Biochemistry and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.